Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05053126 · ClinicalTrials.gov registry record · Phase 4
Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users
A Phase 4 study, sponsored by Viatris Specialty.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT05053126 is a Phase 4 study that has completed, run by Viatris Specialty. The registered enrollment target is 60 participants.
The verdict
NCT05053126, a Phase 4 study, has completed, sponsored by Viatris Specialty.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a Phase 4 clinical study in healthy non-drug dependent recreational opioid users to assess the abuse potential of Lyrica when taken alone or in combination with oxycodone.
Interventions
- DRUG Pregabalin 300mg
- DRUG pregabalin 450 mg
- DRUG Pregabalin 300 mg with oxycodone 20 mg
- DRUG pregabalin 450 mg with oxycodone 20 mg
- DRUG oxycodone 20 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-07-27 |
| Est. Completion | 2022-04-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05053126
The ClinicalTrials.gov registry entry for NCT05053126 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Viatris Specialty, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Pregabalin 300mg is the first listed.
NCT05053126 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05053126 about?
NCT05053126 is a clinical study titled "Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users". This is a Phase 4 clinical study in healthy non-drug dependent recreational opioid users to assess the abuse potential of Lyrica when taken alone or in combination with oxycodone.
What is the current status of trial NCT05053126?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2021-07-27. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT05053126?
The interventions under investigation include: Pregabalin 300mg (DRUG), pregabalin 450 mg (DRUG), Pregabalin 300 mg with oxycodone 20 mg (DRUG), pregabalin 450 mg with oxycodone 20 mg (DRUG), oxycodone 20 mg (DRUG).
Who is sponsoring clinical trial NCT05053126?
This trial is sponsored by Viatris Specialty, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.